A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease

Blood

Volumn 97, Issue 5, 2001, Pages 1249-1257

  Thomis, Daniel C ^a   Marktel, Sarah ^b   Bonini, Chiara ^b   Traversari, Catia ^b   Gilman, Michael ^b   Bordignon, Claudio ^b   Clackson, Tim ^a  

^a ARIAD PHARMACEUTICALS INC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AP 1903; FAS ANTIGEN; FK 506 BINDING PROTEIN; HERPES SIMPLEX VIRUS THYMIDINE KINASE GANCICLOVIR; IMMUNOLOGIC AGENT; NERVE GROWTH FACTOR RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; GENE THERAPY; GENETIC TRANSDUCTION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNOGENICITY; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIDE EFFECT; SUICIDE GENE; T LYMPHOCYTE;

ANTIGENS, CD95; APOPTOSIS; BONE MARROW TRANSPLANTATION; CROSS-LINKING REAGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE REARRANGEMENT; GRAFT VS HOST DISEASE; HUMANS; IMMUNOMAGNETIC SEPARATION; LYMPHOCYTE ACTIVATION; ORGANIC CHEMICALS; RECOMBINANT FUSION PROTEINS; RETROVIRIDAE; T-LYMPHOCYTES; TACROLIMUS BINDING PROTEINS; TIME FACTORS; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 0035282726     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.5.1249     Document Type: Article

References (43)

1. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients: European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia
2. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia
3. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones
4. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients
5. Use of donor T-lymphocytes expressing herpes-simplex thymidine kinase in allogeneic bone marrow transplantation: A phase I-II study
6. Clinical protocol: Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation
7. In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase
8. Retrovirally transduced Escherichia coli gpt genes combine selectability with chemosensitivity capable of mediating tumor eradication
9. Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: An approach for specific in vivo donor T-cell depletion after bone marrow transplantation?
10. Prevention of graft-versus-host disease in mice using a suicide gene expressed in T lymphocytes
11. Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graftversus-leukemia: Clinical follow-up and improved new vectors
12. Death receptors: Signaling and modulation
13. Cell death: The Significance of apoptosis
14. A versatile synthetic dimenzer for the regulation of protein-protein interactions
15. Functional analysis of Fas signaling in vivo using synthetic inducers of dimerization
16. Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity
17. Cell-surface tagging and a suicide mechanism in a single chimeric human protein
18. Applications of retrovirus-mediated expression cloning
19. Synthetic activation of caspases: Artificial death switches
20. - T-cell depletion does not prevent graft-versus-host disease
21. Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant
22. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages
23. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis
24. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl
25. Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex
26. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing
27. Relationship between proliferation and susceptibility to CD95- and CD2-mediated apoptosis in stimulated primary T lymphocytes: T cells manifesting proliferative unresponsiveness are preferentially susceptible to CD95-mediated apoptosis
28. The extracellular signal-regulated kinase pathway is required for activation-induced cell death of T cells
29. Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHalpha1) death signal
30. Molecular ordering of the cell death pathway: Bcl-2 and Bcl-xL function upstream of the CED-3-like apoptotic proteases
31. Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death
32. X-linked 1AP is a direct inhibitor of cell-death proteases
33. Inhibition of death receptor signals by cellular FLIP
34. The role of APO-1-mediated apoptosis in the immune system
35. The role of the Caspase family of cysteine proteases in apoptosis
36. Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis
37. Portrait of an executioner: The molecular mechanism of FAS/APO-1-induced apoptosis
38. Examination of the sensitivity of T cells to Fas ligation: Induction of allospecific apoptosis
39. Self-association of the "death domains" of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects
40. Creating conditional mutations in mammals
41. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients
42. Treatment of cytomegalovirus diseases
43. Antiviral activity and mechanism of action of ganciclovir